(19)
(11) EP 4 681 208 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24712799.6

(22) Date of filing: 15.03.2024
(51) International Patent Classification (IPC): 
G16B 40/20(2019.01)
G16B 5/00(2019.01)
C07K 14/725(2006.01)
G16B 20/00(2019.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
G16B 20/00; C07K 14/7051; G16B 40/20; G16B 5/00; A61K 39/00; A61P 35/00
(86) International application number:
PCT/EP2024/057046
(87) International publication number:
WO 2024/194208 (26.09.2024 Gazette 2024/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 17.03.2023 GB 202303920

(71) Applicant: T-Cypher Bio Ltd
Oxford OX4 4DQ (GB)

(72) Inventors:
  • O'BRIEN, Hugh
    Oxford (GB)
  • SALM-HORSTMAR, Maximilian Prinz zu
    Oxford (GB)

(74) Representative: AWA Sweden AB 
Matrosgatan 1 Box 5117
200 71 Malmö
200 71 Malmö (SE)

   


(54) PREDICTION OF IMMUNOGENICITY